TrialSignal transduction and targeted therapy2026
Efficacy and safety of ifupinostat in relapsed or refractory diffuse large B-cell lymphoma: a multicenter, single-arm phase 2 study.
Yuankai Shi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.